rs45562031

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_000342.4(SLC4A1):​c.118G>A​(p.Glu40Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0145 in 1,614,150 control chromosomes in the GnomAD database, including 222 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.011 ( 13 hom., cov: 32)
Exomes 𝑓: 0.015 ( 209 hom. )

Consequence

SLC4A1
NM_000342.4 missense

Scores

2
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:2U:1B:12

Conservation

PhyloP100: 0.681

Publications

24 publications found
Variant links:
Genes affected
SLC4A1 (HGNC:11027): (solute carrier family 4 member 1 (Diego blood group)) The protein encoded by this gene is part of the anion exchanger (AE) family and is expressed in the erythrocyte plasma membrane, where it functions as a chloride/bicarbonate exchanger involved in carbon dioxide transport from tissues to lungs. The protein comprises two domains that are structurally and functionally distinct. The N-terminal 40kDa domain is located in the cytoplasm and acts as an attachment site for the red cell skeleton by binding ankyrin. The glycosylated C-terminal membrane-associated domain contains 12-14 membrane spanning segments and carries out the stilbene disulphonate-sensitive exchange transport of anions. The cytoplasmic tail at the extreme C-terminus of the membrane domain binds carbonic anhydrase II. The encoded protein associates with the red cell membrane protein glycophorin A and this association promotes the correct folding and translocation of the exchanger. This protein is predominantly dimeric but forms tetramers in the presence of ankyrin. Many mutations in this gene are known in man, and these mutations can lead to two types of disease: destabilization of red cell membrane leading to hereditary spherocytosis, and defective kidney acid secretion leading to distal renal tubular acidosis. Other mutations that do not give rise to disease result in novel blood group antigens, which form the Diego blood group system. Southeast Asian ovalocytosis (SAO, Melanesian ovalocytosis) results from the heterozygous presence of a deletion in the encoded protein and is common in areas where Plasmodium falciparum malaria is endemic. One null mutation in this gene is known, resulting in very severe anemia and nephrocalcinosis. [provided by RefSeq, Jul 2008]
SLC4A1 Gene-Disease associations (from GenCC):
  • cryohydrocytosis
    Inheritance: AD, Unknown Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: PanelApp Australia, Orphanet, Labcorp Genetics (formerly Invitae)
  • hereditary spherocytosis type 4
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • southeast Asian ovalocytosis
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • autosomal dominant distal renal tubular acidosis
    Inheritance: AR, AD Classification: STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • renal tubular acidosis, distal, 4, with hemolytic anemia
    Inheritance: AR, AD Classification: STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Orphanet, Labcorp Genetics (formerly Invitae)
  • dehydrated hereditary stomatocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary spherocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000342.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.044904858).
BP6
Variant 17-44261625-C-T is Benign according to our data. Variant chr17-44261625-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 17756.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0111 (1690/152288) while in subpopulation NFE AF = 0.018 (1224/68002). AF 95% confidence interval is 0.0172. There are 13 homozygotes in GnomAd4. There are 744 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 13 AD,AR,Unknown gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000342.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC4A1
NM_000342.4
MANE Select
c.118G>Ap.Glu40Lys
missense
Exon 4 of 20NP_000333.1P02730-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC4A1
ENST00000262418.12
TSL:1 MANE Select
c.118G>Ap.Glu40Lys
missense
Exon 4 of 20ENSP00000262418.6P02730-1
SLC4A1
ENST00000399246.3
TSL:5
c.118G>Ap.Glu40Lys
missense
Exon 4 of 15ENSP00000382190.3A0A0A0MS98
SLC4A1
ENST00000471005.5
TSL:3
n.52G>A
non_coding_transcript_exon
Exon 2 of 4

Frequencies

GnomAD3 genomes
AF:
0.0111
AC:
1691
AN:
152170
Hom.:
13
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00314
Gnomad AMI
AF:
0.112
Gnomad AMR
AF:
0.00655
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00228
Gnomad FIN
AF:
0.00904
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0180
Gnomad OTH
AF:
0.00956
GnomAD2 exomes
AF:
0.0105
AC:
2638
AN:
251402
AF XY:
0.0105
show subpopulations
Gnomad AFR exome
AF:
0.00289
Gnomad AMR exome
AF:
0.00642
Gnomad ASJ exome
AF:
0.000893
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00896
Gnomad NFE exome
AF:
0.0178
Gnomad OTH exome
AF:
0.0121
GnomAD4 exome
AF:
0.0149
AC:
21724
AN:
1461862
Hom.:
209
Cov.:
33
AF XY:
0.0145
AC XY:
10530
AN XY:
727234
show subpopulations
African (AFR)
AF:
0.00311
AC:
104
AN:
33480
American (AMR)
AF:
0.00684
AC:
306
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
30
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39698
South Asian (SAS)
AF:
0.00243
AC:
210
AN:
86258
European-Finnish (FIN)
AF:
0.0101
AC:
540
AN:
53418
Middle Eastern (MID)
AF:
0.00156
AC:
9
AN:
5768
European-Non Finnish (NFE)
AF:
0.0178
AC:
19790
AN:
1111984
Other (OTH)
AF:
0.0121
AC:
733
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
1237
2475
3712
4950
6187
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
708
1416
2124
2832
3540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0111
AC:
1690
AN:
152288
Hom.:
13
Cov.:
32
AF XY:
0.00999
AC XY:
744
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.00313
AC:
130
AN:
41566
American (AMR)
AF:
0.00647
AC:
99
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5182
South Asian (SAS)
AF:
0.00228
AC:
11
AN:
4826
European-Finnish (FIN)
AF:
0.00904
AC:
96
AN:
10622
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0180
AC:
1224
AN:
68002
Other (OTH)
AF:
0.00946
AC:
20
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
85
169
254
338
423
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0155
Hom.:
50
Bravo
AF:
0.0111
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.0150
EpiControl
AF:
0.0162

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
5
not provided (6)
1
-
3
Hereditary spherocytosis type 4 (4)
-
-
1
Autosomal dominant distal renal tubular acidosis (1)
1
-
-
Cryohydrocytosis (1)
-
-
1
Distal renal tubular acidosis (1)
-
-
1
Hemolytic anemia (1)
-
-
1
SLC4A1-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.33
CADD
Benign
16
DANN
Uncertain
0.98
DEOGEN2
Benign
0.28
T
Eigen
Benign
-0.95
Eigen_PC
Benign
-0.99
FATHMM_MKL
Benign
0.051
N
LIST_S2
Benign
0.85
D
MetaRNN
Benign
0.045
T
MetaSVM
Benign
-0.95
T
MutationAssessor
Uncertain
2.7
M
PhyloP100
0.68
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-1.0
N
REVEL
Benign
0.21
Sift
Benign
0.20
T
Sift4G
Benign
0.49
T
Varity_R
0.12
gMVP
0.21
Mutation Taster
=96/4
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
3.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs45562031;
hg19: chr17-42338993;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.